Liposome-coated lipoplex-based carrier for antisense oligonucleotides.
Cancer Biol Ther
; 16(1): 66-76, 2015.
Article
en En
| MEDLINE
| ID: mdl-25482931
Palabras clave
AML, acute myeloid leukemia; BCL-2 gene; Bcl-2, B-cell lymphoma 2 protein; CCL, coated cationic liposomes; DC-CHOL, 3ß-(N-[dimethylaminoethane]carbamoyl)cholesterol) DiD-1,1', dioctadecyl-3,3,3', 3'-tetramethylindodicarbocyanine; DOPE, 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine); DOTAP, 1, 2-dioleoyl-3-trimethylammonium-propane); DSPE, PEG-(1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[amino(polyethylene glycol)2000] (ammonium salt); GFP, green fluorescent protein; HPC, hydrogenated egg phosphatidylcholine); L-cL, liposome-coated lipoplex; PE/PC, phosphatidylethanolamine and phosphatidylcholine liposomes; acute leukemia; antisense deoxynucleotides; asODN, antisense oligodeoxynucleotide; cationic lipids; gene therapy; lipid carrier; lipoplex; liposome coated lipoplex; pDNA, plasmid DNA; siRNA, small interferingRNA TGI, tumor growth inhibition
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Portadores de Fármacos
/
Oligonucleótidos Antisentido
/
Liposomas
Tipo de estudio:
Prognostic_studies
Límite:
Animals
/
Female
/
Humans
/
Male
Idioma:
En
Revista:
Cancer Biol Ther
Asunto de la revista:
NEOPLASIAS
/
TERAPEUTICA
Año:
2015
Tipo del documento:
Article
País de afiliación:
Polonia
Pais de publicación:
Estados Unidos